Terms: = Leukemia AND PICALM, CLTH, 8301, ENSG00000073921, CALM, Q13492 AND Prognosis
15 results:
1. Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.
Abla O; Ries RE; Triche T; Gerbing RB; Hirsch B; Raimondi S; Cooper T; Farrar JE; Buteyn N; Harmon LM; Wen H; Deshpande AJ; Kolb EA; Gamis AS; Aplenc R; Alonzo T; Meshinchi S
Blood Adv; 2024 Apr; 8(8):2005-2017. PubMed ID: 38306602
[TBL] [Abstract] [Full Text] [Related]
2. Treatment outcomes of childhood picalm::MLLT10 acute leukaemias.
Mark C; Meshinchi S; Joyce B; Gibson B; Harrison C; Bergmann AK; Goemans BF; Pronk CJH; Lapillonne H; Leverger G; Antoniou E; Schneider M; Attarbaschi A; Dworzak M; Stary J; Tomizawa D; Ebert S; Lejman M; Kolb EA; Schmiegelow K; Hasle H; Abla O
Br J Haematol; 2024 Feb; 204(2):576-584. PubMed ID: 37743097
[TBL] [Abstract] [Full Text] [Related]
3. RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification.
Yang Y; Shu Y; Tang Y; Zhao S; Jia Y; Ji J; Ma H; Lin T; Zheng K; Xu H; Wu Y
Cancer Med; 2023 Apr; 12(8):9156-9166. PubMed ID: 36916780
[TBL] [Abstract] [Full Text] [Related]
4. UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (calm): a phase 1, dose-escalation trial.
Benjamin R; Jain N; Maus MV; Boissel N; Graham C; Jozwik A; Yallop D; Konopleva M; Frigault MJ; Teshima T; Kato K; Boucaud F; Balandraud S; Gianella-Borradori A; Binlich F; Marchiq I; Dupouy S; Almena-Carrasco M; Pannaux M; Fouliard S; Brissot E; Mohty M;
Lancet Haematol; 2022 Nov; 9(11):e833-e843. PubMed ID: 36228643
[TBL] [Abstract] [Full Text] [Related]
5. Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins.
Steimlé T; Dourthe ME; Alcantara M; Touzart A; Simonin M; Mondesir J; Lhermitte L; Bond J; Graux C; Grardel N; Cayuela JM; Arnoux I; Gandemer V; Balsat M; Vey N; Macintyre E; Ifrah N; Dombret H; Petit A; Baruchel A; Ruminy P; Boissel N; Asnafi V
Blood Cancer J; 2022 Jan; 12(1):14. PubMed ID: 35082269
[TBL] [Abstract] [Full Text] [Related]
6. A JAK/STAT-mediated inflammatory signaling cascade drives oncogenesis in AF10-rearranged AML.
Chen BR; Deshpande A; Barbosa K; Kleppe M; Lei X; Yeddula N; Vela PS; Campos AR; Wechsler-Reya RJ; Bagchi A; Meshinchi S; Eaves C; Jeremias I; Haferlach T; Frank DA; Ronai Z; Chanda S; Armstrong SA; Adams PD; Levine RL; Deshpande AJ
Blood; 2021 Jun; 137(24):3403-3415. PubMed ID: 33690798
[TBL] [Abstract] [Full Text] [Related]
7. The prognosis of calm-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.
Ben Abdelali R; Asnafi V; Petit A; Micol JB; Callens C; Villarese P; Delabesse E; Reman O; Lepretre S; Cahn JY; Guillerm G; Berthon C; Gardin C; Corront B; Leguay T; Béné MC; Ifrah N; Leverger G; Dombret H; Macintyre E
Haematologica; 2013 Nov; 98(11):1711-7. PubMed ID: 23831922
[TBL] [Abstract] [Full Text] [Related]
8. The clathrin-binding domain of calm and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice.
Deshpande AJ; Rouhi A; Lin Y; Stadler C; Greif PA; Arseni N; Opatz S; Quintanilla-Fend L; Holzmann K; Hiddemann W; Döhner K; Döhner H; Xu G; Armstrong SA; Bohlander SK; Buske C
Leukemia; 2011 Nov; 25(11):1718-27. PubMed ID: 21681188
[TBL] [Abstract] [Full Text] [Related]
9. Acute leukemia with picalm-MLLT10 fusion gene: diagnostic and treatment struggle.
Savage NM; Kota V; Manaloor EJ; Kulharya AS; Pierini V; Mecucci C; Ustun C
Cancer Genet Cytogenet; 2010 Oct; 202(2):129-32. PubMed ID: 20875875
[TBL] [Abstract] [Full Text] [Related]
10. Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.
Huh JY; Chung S; Oh D; Kang MS; Eom HS; Cho EH; Han MH; Kong SY
Korean J Lab Med; 2010 Apr; 30(2):117-21. PubMed ID: 20445327
[TBL] [Abstract] [Full Text] [Related]
11. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract] [Full Text] [Related]
12. [calm-AF10 fusion transcripts in primary leukemia with t(10;11) and in vitro chemotherapy sensitivity of leukemic cells with t(10;11)].
Ou DM; Liu GX; Yan JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):770-3. PubMed ID: 15631658
[TBL] [Abstract] [Full Text] [Related]
13. Incidence of MLL rearrangement in acute myeloid leukemia, and a calm-AF10 fusion in M4 type acute myeloblastic leukemia.
Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D
Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
[TBL] [Abstract] [Full Text] [Related]
14. MLL and calm are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis.
Dreyling MH; Schrader K; Fonatsch C; Schlegelberger B; Haase D; Schoch C; Ludwig W; Löffler H; Büchner T; Wörmann B; Hiddemann W; Bohlander SK
Blood; 1998 Jun; 91(12):4662-7. PubMed ID: 9616163
[TBL] [Abstract] [Full Text] [Related]
15. [Chronic lympholeukemia. I. Clinical variants].
Popova L; Apostolov P; Vlaĭkova S; Stamenova T
Vutr Boles; 1988; 27(2):67-70. PubMed ID: 3414103
[TBL] [Abstract] [Full Text] [Related]
